DexCom Inc (DXCM)
Return on assets (ROA)
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 541,500 | 341,200 | 216,900 | 549,700 | 101,100 |
Total assets | US$ in thousands | 6,264,500 | 5,391,700 | 4,933,300 | 4,290,500 | 2,395,000 |
ROA | 8.64% | 6.33% | 4.40% | 12.81% | 4.22% |
December 31, 2023 calculation
ROA = Net income ÷ Total assets
= $541,500K ÷ $6,264,500K
= 8.64%
Dexcom Inc's return on assets (ROA) has shown fluctuations over the past five years. The company's ROA was 8.64% in 2023, indicating that it generated 8.64 cents of profit for every dollar of assets. This represents an improvement compared to the previous year, where the ROA was 6.33%. In 2021, the ROA was 3.18%, reflecting a lower profitability relative to the following years.
In 2020, Dexcom Inc's ROA significantly increased to 11.50%, showcasing strong asset utilization and profitability. However, in 2019, the ROA was at 4.22%, indicating a moderate performance in utilizing its assets to generate profits.
Overall, the trend in Dexcom Inc's ROA has been positive in recent years, with fluctuations reflecting changes in the company's efficiency in generating profits from its assets. Further analysis of the company's financial performance and asset management strategies could provide insights into the drivers behind these fluctuations.
Peer comparison
Dec 31, 2023